Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials

Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology
Mary E Lynch, Mark A Ware

Abstract

An updated systematic review of randomized controlled trials examining cannabinoids in the treatment of chronic non-cancer pain was conducted according to PRISMA guidelines for systematic reviews reporting on health care outcomes. Eleven trials published since our last review met inclusion criteria. The quality of the trials was excellent. Seven of the trials demonstrated a significant analgesic effect. Several trials also demonstrated improvement in secondary outcomes (e.g., sleep, muscle stiffness and spasticity). Adverse effects most frequently reported such as fatigue and dizziness were mild to moderate in severity and generally well tolerated. This review adds further support that currently available cannabinoids are safe, modestly effective analgesics that provide a reasonable therapeutic option in the management of chronic non-cancer pain.

References

Feb 13, 2001·Pain·F M BlythM J Cousins
Jul 27, 2001·Proceedings of the National Academy of Sciences of the United States of America·B F CravattA H Lichtman
Jan 9, 2003·Pain Research & Management : the Journal of the Canadian Pain Society = Journal De La Société Canadienne Pour Le Traitement De La Douleur·Dwight E MoulinPatricia K Morley-Forster
Aug 13, 2005·European Journal of Pain : EJP·Harald BreivikDerek Gallacher
Jul 22, 2008·Rheumatic Diseases Clinics of North America·Mary E Lynch
Dec 17, 2009·Anesthesia and Analgesia·Mark A WareYoram Shir
Aug 14, 2010·Pain·Nanna Brix FinnerupTroels Staehelin Jensen
Mar 24, 2011·British Journal of Clinical Pharmacology·Mary E Lynch, Fiona Campbell
Apr 19, 2011·Pain Research & Management : the Journal of the Canadian Pain Society = Journal De La Société Canadienne Pour Le Traitement De La Douleur·Mary E Lynch
May 16, 2012·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Jody Corey-BloomBen Gouaux
Jul 14, 2012·Journal of Neurology, Neurosurgery, and Psychiatry·John Peter ZajicekUNKNOWN MUSEC Research Group
Oct 31, 2012·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Stephen D Skaper, Vincenzo Di Marzo
Oct 31, 2012·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Roger G Pertwee
Dec 15, 2012·The Journal of Pain : Official Journal of the American Pain Society·Barth WilseyHaylee Donaghe
Oct 8, 2014·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Dana TurcotteMike Namaka

❮ Previous
Next ❯

Citations

Feb 7, 2016·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Pierre BeaulieuAlexander J Clark
Feb 13, 2016·Frontiers in Plant Science·Christelle M AndreGea Guerriero
Jul 1, 2015·The International Journal on Drug Policy·Lisa StolzenbergDustin Dariano
Jan 24, 2016·Frontiers in Neuroendocrinology·Edward J Wagner
Mar 1, 2016·Pharmacotherapy·Corey C Tsang, Mirella G Giudice
Mar 11, 2016·The Journal of Pain : Official Journal of the American Pain Society·Seddon R SavageMark Ware
Nov 19, 2015·Journal of Basic and Clinical Physiology and Pharmacology·Mary E Lynch
Oct 16, 2015·Harm Reduction Journal·Sharon R Sznitman, Anne Line Bretteville-Jensen
Nov 17, 2015·PM & R : the Journal of Injury, Function, and Rehabilitation·Bradford W LandryJoline E Brandenburg
Aug 2, 2015·Progress in Neuro-psychopharmacology & Biological Psychiatry·Colin Davidson, Fabrizio Schifano
Jun 10, 2015·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Guy A CabralAron H Lichtman
Jul 19, 2016·Forensic Toxicology·Cornelius HessChrista E Müller
Nov 17, 2016·Nature·Zhenhua ShaoDaniel M Rosenbaum
Jan 17, 2017·Acta Anaesthesiologica Scandinavica·A J Stevens, M D Higgins
Jul 28, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Judith A PaiceEduardo Bruera
Sep 16, 2017·Behavioural Pharmacology·Rebecca M CraftAlexa A Wakley
Aug 16, 2017·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Ziva D Cooper, Rebecca M Craft
Sep 1, 2017·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Giulia DonvitoAron H Lichtman
Jun 18, 2017·Medwave·Rubén F Allende-Salazar, Gabriel Rada
May 26, 2017·Anesthesia and Analgesia·Howard MengAnuj Bhatia
Feb 10, 2018·Irish Journal of Medical Science·Ciaran RochfordDominic Harmon
Jun 18, 2019·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Monika HaackJanet Mullington
Jul 26, 2019·Current Pain and Headache Reports·Ivan UritsOmar Viswanath
Nov 20, 2019·Clinical EEG and Neuroscience·Kristina AdorjanOliver Pogarell
Feb 28, 2020·Palliative Medicine·Megan DohertyChristina Vadeboncoeur
Apr 9, 2020·Journal of Psychopharmacology·Cecilia L BergeriaKelly E Dunn
Jun 3, 2020·The Annals of Pharmacotherapy·Shannon IngletWhitney Mortensen
Mar 30, 2017·Current Psychiatry Reports·Kimberly A BabsonDanielle Morabito
Jan 13, 2019·European Archives of Psychiatry and Clinical Neuroscience·Gabrielle CampbellSuzanne Nielsen
Aug 23, 2017·British Journal of Sports Medicine·Brian HainlineLars Engebretsen
Dec 12, 2019·Systematic Reviews·Misty PrattBrian Hutton
Feb 6, 2020·BMC Complementary Medicine and Therapies·Nadia Montero-OleasDaniel Simancas-Racines
Aug 1, 2018·Laryngoscope Investigative Otolaryngology·Lucas M BryantJoseph M Curry
Dec 14, 2018·Frontiers in Pharmacology·Sonja VučkovićMilica Prostran

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.